Trends and developments in MRI contrast agent research

被引：0
|
作者：
F. M. Cavagna
M. Dapra`
P. M. Castelli
F. Maggioni
M. A. Kirchin
机构：
[1] Bracco SpA,
[2] via Egidio Folli 50,undefined
[3] I-20 134 Milan,undefined
[4] Italy,undefined
来源：
European Radiology | 1997年 / 7卷
关键词：
Key words: MRI contrast agents; Liver imaging; Blood pool agents; MRA; Tissue-targeting;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
The currently prevailing trends in industrial contrast agent research for MRI are discussed. Specific mention is made of contrast agents for liver imaging using both static and delayed procedures, of the potential for blood pool agents and the form such agents may take, and of the ultimate challenge for contrast agent R&D: tissue-targeting in a wider sense to both normal and pathologic tissues.
引用
收藏
页码：S222 / S224
相关论文
共 48 条
  • [1] Trends and developments in MRI contrast agent research
    Cavagna, FM
    Dapra, M
    Castelli, PM
    Maggioni, F
    Kirchin, MA
    EUROPEAN RADIOLOGY, 1997, 7 (Suppl 5) : S222 - S224
  • [2] A polymeric micelle MRI contrast agent with changeable relaxivity
    Nakamura, Emiko
    Makino, Kimiko
    Okano, Teruo
    Yamamoto, Tatsuhiro
    Yokoyama, Masayuki
    JOURNAL OF CONTROLLED RELEASE, 2006, 114 (03) : 325 - 333
  • [3] Quantitative optimisation of MRI contrast agent dose using response surface modelling
    Fkirin, M. A.
    Badway, Samir Mohammed
    Barakat, Ehab
    INTERNATIONAL JOURNAL OF BIOMEDICAL ENGINEERING AND TECHNOLOGY, 2016, 22 (01) : 58 - 65
  • [4] MULTIMODALITY COMPARATIVE STUDY: QUANTITATIVE ASSESSMENT OF MRI CONTRAST AGENT DOSE REDUCTION
    Badway, S. M.
    Fkirin, M. A.
    Barakat, E. H.
    BIOMEDICAL ENGINEERING-APPLICATIONS BASIS COMMUNICATIONS, 2016, 28 (01):
  • [5] MRI of hepatic adenomatosis: Initial observations with gadoxetic acid contrast agent in three patients
    Giovanoli, Olivier
    Heim, Markus
    Terracciano, Luigi
    Bongartz, Georg
    Ledermann, Hans P.
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2008, 190 (05) : W290 - W293
  • [6] Real-time MRI monitoring of transcatheter hepatic artery contrast agent delivery in rabbits
    Sato, KT
    Larson, AC
    Rhee, TK
    Salem, RA
    Nemcek, AA
    Mounajjed, T
    Paunesku, T
    Woloschak, G
    Nikolaides, P
    Omary, RA
    ACADEMIC RADIOLOGY, 2005, 12 (10) : 1342 - 1350
  • [7] Biomimetic MRI Contrast Agent for Imaging of Inflammation in Atherosclerotic Plaque of ApoE-/- Mice A Pilot Study
    Alsaid, Hasan
    De Souza, Genevieve
    Bourdillon, Marie-Claude
    Chaubet, Frederic
    Sulaiman, Abdulrazzag
    Desbleds-Mansard, Catherine
    Chaabane, Linda
    Zahir, Charaf
    Lancelot, Eric
    Rousseaux, Olivier
    Corot, Claire
    Douek, Philippe
    Briguet, Andre
    Letourneur, Didier
    Canet-Soulas, Emmanuelle
    INVESTIGATIVE RADIOLOGY, 2009, 44 (03) : 151 - 158
  • [8] Ferucarbotran (Resovist): a new clinically approved RES-specific contrast agent for contrast-enhanced MRI of the liver: properties, clinical development, and applications
    Reimer, P
    Balzer, T
    EUROPEAN RADIOLOGY, 2003, 13 (06) : 1266 - 1276
  • [9] Manganese (II) Complex of 1,4,7-Triazacyclononane-1,4,7-Triacetic Acid (NOTA) as a Hepatobiliary MRI Contrast Agent
    Islam, Md. Kamrul
    Baek, Ah-Rum
    Yang, Byeong-Woo
    Kim, Soyeon
    Hwang, Dong Wook
    Nam, Sung-Wook
    Lee, Gang-Ho
    Chang, Yongmin
    PHARMACEUTICALS, 2023, 16 (04)
  • [10] THE EFFECT OF RESPIRATION ON THE CONTRAST AND SHARPNESS OF LIVER-LESIONS IN MRI
    BUTTS, K
    RIEDERER, SJ
    EHMAN, RL
    MAGNETIC RESONANCE IN MEDICINE, 1995, 33 (01) : 1 - 7
12345